- Report
- September 2022
- 67 Pages
Global
- Report
- June 2023
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- March 2023
- 254 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- June 2019
- 144 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- October 2023
- 120 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2023
- 119 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- August 2022
- 120 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 189 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2023
- 112 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 117 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 175 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 181 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 178 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- November 2023
- 160 Pages
South Korea
From €2979EUR$2,999USD£2,477GBP
- Report
- November 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- October 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- September 2023
- 160 Pages
Global
From €2979EUR$2,999USD£2,477GBP
The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more